BUSM’s Kurosawa Joins NIH Study Section

E. coli Enterohemorrhagic (EHEC) (photo courtesy of heal-all.org)
E. coli Enterohemorrhagic (EHEC) (photo courtesy of heal-all.org)

Shinichiro Kurosawa, MD, PhD, associate professor of pathology & laboratory medicine, has accepted an invitation from the Center for the Scientific Review at the National Institutes of Health (NIH) as a member of the Host Interactions with Bacterial Pathogens Study Section.  Study section responsibilities include ensuring the quality of the NIH’s peer review process by objectively evaluating grant applications concerning infectious disease research and ultimately improve patient care and make recommendations to the appropriate NIH national advisory council/board. Participation in a study section presents a unique opportunity to contribute to the national biomedical research effort and requires a significant commitment of professional time. According to the NIH, Kurosawa was chosen as a result of his knowledge, proficiency and achievement in his field as evidenced by the quality of research accomplishments, publications in scientific journals, and other significant scientific activities, achievements and honors.

His laboratory strives to bring new therapeutics and novel diagnostics to patients using in vitro approaches and model systems including pre-clinical models of diseases. He focuses on translational medicine especially in the field of sepsis, inflammation, thrombosis and hemostasis.